Study identifier:NIS-OSE-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A retrospective, medical record study to investigate the current situation of biopsy testing in the Swedish inoperable Non Small Cell Lung Cancer patient population
Non Small Cell Lung Cancer
-
No
-
All
136
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Inoperable non small cell lung cancer patients. Diagnosed between 2010-05-31 and 2009-06-01. | - |